Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 24 peer-reviewed journal articles Updated
Pediatric Neurology · Paroxysmal Dystonic Choreoathetosis with Episodic Ataxia and Spasticity

Understanding Your Diagnosis: Paroxysmal Dystonic Choreoathetosis with Episodic Ataxia and Spasticity

At a Glance

Paroxysmal dystonic choreoathetosis with episodic ataxia and spasticity describes a group of movement disorders that can cause sudden attacks, balance problems, and stiffness. Episodes often preserve awareness, but video and genetic testing may help clarify the cause.

Receiving a diagnosis with a name as complex as Paroxysmal Dystonic Choreoathetosis with Episodic Ataxia and Spasticity can feel overwhelming. It is helpful to think of this not as a single disease, but as a descriptive “map” of how your child’s nervous system is currently reacting [1][2]. This label describes a spectrum of overlapping movement disorders where the symptoms often share the same genetic “neighborhood” [3][4].

Breaking Down the Terms

To understand what is happening, it helps to decode the medical language used to describe these movements:

  • Paroxysmal: This means the symptoms are not constant; they come in sudden attacks or “spells” [2].
  • Dystonic (Dystonia): This refers to involuntary muscle contractions that cause twisting or repetitive movements and unusual postures [2][5].
  • Choreoathetosis: This is a combination of two types of movements: chorea (irregular, jerky, “dance-like” movements) and athetosis (slow, writhing, snake-like movements) [2][6].
  • Episodic Ataxia: These are distinct periods of loss of coordination, balance, or “clumsiness” that often involve the brain’s coordination center, the cerebellum [1][2].
  • Spasticity: This is a specific type of muscle stiffness or tightness that can make movements feel rigid or “catchy” [5].

The Nature of the Attacks

A defining feature of a typical attack in these conditions is that your child remains fully conscious [2][7]. While the movements may look similar to a seizure, your child is aware of what is happening, can often remember the event afterward, and does not lose track of their surroundings. However, preserved awareness does not by itself rule out a seizure, as some focal seizures can occur with preserved consciousness [7].

The “paroxysmal” nature means your child may seem completely typical between episodes [1]. However, in cases that include ataxia or spasticity, some mild symptoms like stiffness or balance issues might persist even when an active attack is not happening [8][5].

When and Why it Starts

For many families, symptoms first appear during childhood or early adolescence. The exact age of onset varies widely by the specific underlying gene; for example, PRRT2-related PKD often starts around age 8 to 12 [6][9]. These attacks are often “triggered” by specific events. Identifying these triggers is a key clue rather than a way to establish the gene:

  • Kinesigenic: Triggered by sudden voluntary movement, like jumping up from a chair [6].
  • Non-kinesigenic: Triggered by things like stress, caffeine, or alcohol [10].
  • Exertion-induced: Triggered by prolonged physical exercise or fasting [11][12].

An Overlapping Genetic Spectrum

Modern medicine views these symptoms as a spectrum rather than separate boxes. Different genes can cause very similar symptoms, and one single gene can cause different symptoms in different people—even within the same family [13][14].

Common genetic pathways involved in this spectrum include:

  • SLC2A1: Related to how the brain gets sugar (glucose). Issues here can cause ataxia, dystonia, and spasticity, especially when hungry or tired [11][15].
  • PRRT2: Frequently linked to sudden, brief movements (choreoathetosis) triggered by activity [16][17].
  • KCNA1 and CACNA1A: These affect the “channels” that control electrical signals in the brain, often leading to episodic ataxia and muscle twitching [18][19].

Navigating the “Diagnostic Odyssey”

It is common for families to experience a long road—often called a diagnostic odyssey—before reaching this description [11][20]. Because the attacks are unpredictable and may not happen in the doctor’s office, they are frequently misdiagnosed as seizures, “clumsiness,” or even psychological issues [21][7].

The uncertainty of when an attack might occur can be a significant source of stress for both you and your child [22]. You are not alone in this; many parents find that recording episodes on a smartphone is the most powerful tool they have to help doctors see the exact nature of the movements [7][23]. Identifying the specific genetic cause can sometimes point toward specific dietary changes or medications that might reduce the frequency of attacks [4][24]. However, a negative genetic panel does not exclude a genetic disorder, and a lumbar puncture for CSF glucose is not automatically required in every child without clinical indication.

Common questions in this guide

What does this diagnosis mean for my child?
It is a descriptive term for a group of related movement disorders rather than one single disease. It refers to sudden episodes of abnormal movements, such as twisting, jerky, or writhing motions, sometimes combined with poor coordination or muscle stiffness.
What can trigger a paroxysmal movement attack?
Triggers vary with the underlying cause and may include a sudden voluntary movement, prolonged exercise, fasting or hunger, stress, caffeine, or alcohol. Keeping a record of what happened before each episode can help the clinician identify patterns.
Does staying conscious mean the episode is not a seizure?
No. Children with these movement attacks are often awake and remember what happened, but some focal seizures also occur with preserved awareness. A clinician may recommend a video-EEG, which records brain electrical activity and behavior during an event, when seizures remain a concern.
Which genes can cause these movement symptoms?
Genes discussed in this spectrum include PRRT2, SLC2A1, KCNA1, and CACNA1A. A genetic result can sometimes guide further evaluation or suggest a diet or medicine that may reduce attacks, while a negative panel does not completely rule out a genetic disorder.
Can symptoms continue between attacks?
Some children appear completely typical between episodes. When ataxia or spasticity is part of the condition, mild balance problems or muscle stiffness may continue even when a sudden attack is not occurring.
How can I help the doctor understand what happens during an episode?
A smartphone video can show the movements when they do not occur during an appointment. Also note possible triggers, whether your child stays aware, and any stiffness, clumsiness, or balance problems between attacks.
Does every child need a lumbar puncture to check for GLUT1 deficiency?
No. A lumbar puncture to measure cerebrospinal-fluid glucose is not automatically required for every child; the decision depends on the symptoms and clinical evaluation. Ask the treating clinician which genetic or metabolic tests are appropriate.

Get notified when new evidence is published on Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (24)
  1. 1

    Genetic Links to Episodic Movement Disorders: Current Insights.

    Garg D, Mohammad S, Shukla A, Sharma S

    The application of clinical genetics 2023; (16()):11-30 doi:10.2147/TACG.S363485.

    PMID: 36883047
  2. 2

    Paroxysmal movement disorders.

    Magrinelli F, Bhatia KP

    Handbook of clinical neurology 2024; (203()):145-156 doi:10.1016/B978-0-323-90820-7.00010-0.

    PMID: 39174246
  3. 3

    Genotype-phenotype relations for episodic ataxia genes: MDSGene systematic review.

    Olszewska DA, Shetty A, Rajalingam R, et al.

    European journal of neurology 2023; (30(10)):3377-3393 doi:10.1111/ene.15969.

    PMID: 37422902
  4. 4

    Paroxysmal Movement Disorders.

    Harvey S, King MD, Gorman KM

    Frontiers in neurology 2021; (12()):659064 doi:10.3389/fneur.2021.659064.

    PMID: 34177764
  5. 5

    Paroxysmal Asymmetric Dystonic Arm Posturing-A Less Recognized but Characteristic Manifestation of ATP1A3-related disease.

    Balint B, Stephen CD, Udani V, et al.

    Movement disorders clinical practice 2019; (6(4)):312-315 doi:10.1002/mdc3.12747.

    PMID: 31061839
  6. 6

    Paroxysmal Dyskinesia in Children: from Genes to the Clinic.

    Kim SY, Lee JS, Kim WJ, et al.

    Journal of clinical neurology (Seoul, Korea) 2018; (14(4)):492-497 doi:10.3988/jcn.2018.14.4.492.

    PMID: 30198221
  7. 7

    [A case of a pathological variant of the PRRT2 gene in twins with paroxysmal kinesiogenic dyskinesia].

    Ermolenko NA, Krasnorutskaya ON, Bykova VA, et al.

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2023; (123(9. Vyp. 2)):83-86 doi:10.17116/jnevro202312309283.

    PMID: 37942977
  8. 8

    Paroxysmal movement disorders: Paroxysmal dyskinesia and episodic ataxia.

    Erro R, Magrinelli F, Bhatia KP

    Handbook of clinical neurology 2023; (196()):347-365 doi:10.1016/B978-0-323-98817-9.00033-8.

    PMID: 37620078
  9. 9

    PRRT2 Mutation and Serum Cytokines in Paroxysmal Kinesigenic Dyskinesia.

    Xu K, Huang SS, Yue DY, et al.

    Current medical science 2022; (42(2)):280-285 doi:10.1007/s11596-022-2583-7.

    PMID: 35438471
  10. 10

    Genetic testing for non-parkinsonian movement disorders: Navigating the diagnostic maze.

    Shambetova C, Klein C

    Parkinsonism & related disorders 2024; (121()):106033 doi:10.1016/j.parkreldis.2024.106033.

    PMID: 38429185
  11. 11

    From splitting GLUT1 deficiency syndromes to overlapping phenotypes.

    Hully M, Vuillaumier-Barrot S, Le Bizec C, et al.

    European journal of medical genetics 2015; (58(9)):443-54.

    PMID: 26193382
  12. 12

    A Challenging Diagnosis of Atypical Glut1-DS: A Case Report and Literature Review.

    Yu M, Miao J, Lv Y, et al.

    Frontiers in neurology 2020; (11()):549331 doi:10.3389/fneur.2020.549331.

    PMID: 33584489
  13. 13

    The relationship between genotype and phenotype in Chinese children with glucose transporter type 1 deficiency syndrome.

    Zhang MJ, Zhang SM, Zhang QP, et al.

    Frontiers in neurology 2025; (16()):1638549 doi:10.3389/fneur.2025.1638549.

    PMID: 41036273
  14. 14

    Glucose Transporter Deficiency Syndrome Type 1 (Glut1-DS): New Insights From a Brazilian Cohort of Patients.

    Sobrinho LMF, Fontana JC, Lorea CF, et al.

    JIMD reports 2026; (67(5)):e70113 doi:10.1002/jmd2.70113.

    PMID: 42638834
  15. 15

    Atypical Manifestations in Glut1 Deficiency Syndrome.

    De Giorgis V, Varesio C, Baldassari C, et al.

    Journal of child neurology 2016; (31(9)):1174-80 doi:10.1177/0883073816650033.

    PMID: 27250207
  16. 16

    Benign infantile seizures and paroxysmal dyskinesia caused by an SCN8A mutation.

    Gardella E, Becker F, Møller RS, et al.

    Annals of neurology 2016; (79(3)):428-36 doi:10.1002/ana.24580.

    PMID: 26677014
  17. 17

    Novel and de novo point and large microdeletion mutation in PRRT2-related epilepsy.

    Yang L, You C, Qiu S, et al.

    Brain and behavior 2020; (10(5)):e01597 doi:10.1002/brb3.1597.

    PMID: 32237035
  18. 18

    Two novel KCNA1 variants identified in two unrelated Chinese families affected by episodic ataxia type 1 and neurodevelopmental disorders.

    Yuan H, Yuan H, Wang Q, et al.

    Molecular genetics & genomic medicine 2020; (8(10)):e1434 doi:10.1002/mgg3.1434.

    PMID: 32705822
  19. 19

    Episodic Ataxias: Primary and Secondary Etiologies, Treatment, and Classification Approaches.

    Hassan A

    Tremor and other hyperkinetic movements (New York, N.Y.) 2023; (13()):9 doi:10.5334/tohm.747.

    PMID: 37008993
  20. 20

    Recent updates in the clinical evaluation and management of pediatric paroxysmal movement disorders.

    Donnellan E, Benson A, Gorman KM

    Current opinion in pediatrics 2026; doi:10.1097/MOP.0000000000001624.

    PMID: 42944601
  21. 21

    Paroxysmal motor disorders: expanding phenotypes lead to coalescing genotypes.

    Zima L, Ceulemans S, Reiner G, et al.

    Annals of clinical and translational neurology 2018; (5(8)):996-1010 doi:10.1002/acn3.597.

    PMID: 30128325
  22. 22

    In search of "what really matters": Insights from a web-based survey on Patient-Centered Outcomes in GLUT1DS.

    Varesio C, Pasca L, Zanaboni MP, et al.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2026; (60()):101-108 doi:10.1016/j.ejpn.2026.01.002.

    PMID: 41638033
  23. 23

    Paroxysmal movement disorders: An update.

    Méneret A, Roze E

    Revue neurologique 2016; (172(8-9)):433-445 doi:10.1016/j.neurol.2016.07.005.

    PMID: 27567459
  24. 24

    The role of molecular analysis of SLC2A1 in the diagnostic workup of glucose transporter 1 deficiency syndrome.

    Takahashi S, Tanaka R, Takeguchi R, et al.

    Journal of the neurological sciences 2020; (416()):117041 doi:10.1016/j.jns.2020.117041.

    PMID: 32712428

This page is for informational purposes only and does not constitute medical advice. Your child’s pediatric neurology and genetics team should interpret episodes, testing, and treatment options.

Guide contents Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity
Research & Literature
02 Fuel and Signals